why choose us

Clinical Trials Search

Showing 9,310 of 132,656 result(s)
The Effect of Essential Oil Inhalation Patches on Perceived Burn-out & Stress on an Inpatient Medical-surgery Unit.

Status: COMPLETED

Condition: Nursing Personnel

Interventions: Each participant will wear a patch for a work week (3 worked shifts) and then no patch is worn for a week.
This alternates for a total of a month

Date: 2023-08-10

Effects of Posterior-anterior Vertebral Mobilization Followed by Prone Press-up Exercise in Nonspecific Low Back Pain

Status: COMPLETED

Condition: Low Back Pain

Interventions:

Posterior-anterior vertebral mobilizations of the lumbar spine are achieved by applying a force on to a spinous process in a posteroanterior direct

Date: 2023-08-10

Eggs for Gut Health

Status: COMPLETED

Condition: Moderate Acute Malnutrition

Interventions: 15g daily dose for 24 weeks

Date: 2023-08-10

A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight

Status: COMPLETED

Condition: Obesity or Overweight

Interventions: Participants will receive 2.4 mg cagrilintide subcutaneously.

Date: 2023-08-10

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

Status: COMPLETED

Condition: SARS-CoV-2 Infection

Interventions: BNT162b2 monovalent (Omicron XBB.1.5)

Date: 2023-08-10

Older Adults' Readiness to Stop Prescribed Medications

Status: COMPLETED

Condition: Polypharmacy, Decision-making

Interventions:

Date: 2023-08-09

Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

Status: COMPLETED

Condition: Hypermobile Ehlers-Danlos Syndrome

Interventions: Transcutaneous Auricular Neurostimulation (tAN) is a wearable, electrical stimulation device that delivers electricity to specific parts of the human

Date: 2023-08-09

Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF)

Status: COMPLETED

Condition: Fusion of Spine, Lumbar Region

Interventions: DRUG: Levobupivacaine - Patients in the tap block arm will receive an injection of levobupivacaine 2.5mg/ml
OTHER: Placebo Tap block - Patients i

Date: 2023-08-09

Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Status: Completed

Condition: Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Interventions:

Date: 2023-08-09